AU2003255866A8 - Gp41 epitope and uses thereof for the treatment of hiv infections - Google Patents

Gp41 epitope and uses thereof for the treatment of hiv infections

Info

Publication number
AU2003255866A8
AU2003255866A8 AU2003255866A AU2003255866A AU2003255866A8 AU 2003255866 A8 AU2003255866 A8 AU 2003255866A8 AU 2003255866 A AU2003255866 A AU 2003255866A AU 2003255866 A AU2003255866 A AU 2003255866A AU 2003255866 A8 AU2003255866 A8 AU 2003255866A8
Authority
AU
Australia
Prior art keywords
epitope
treatment
hiv infections
hiv
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003255866A
Other versions
AU2003255866A1 (en
Inventor
Lucia Lopalco
Mario Clerici
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SAN RAFFAELE CENTRO FOND
Istituto Superiore di Sanita ISS
Universita degli Studi di Milano
Fondazione Centro San Raffaele del Monte Tabor
Original Assignee
SAN RAFFAELE CENTRO FOND
Istituto Superiore di Sanita ISS
Universita degli Studi di Milano
Fondazione Centro San Raffaele del Monte Tabor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SAN RAFFAELE CENTRO FOND, Istituto Superiore di Sanita ISS, Universita degli Studi di Milano, Fondazione Centro San Raffaele del Monte Tabor filed Critical SAN RAFFAELE CENTRO FOND
Publication of AU2003255866A8 publication Critical patent/AU2003255866A8/en
Publication of AU2003255866A1 publication Critical patent/AU2003255866A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003255866A 2002-08-06 2003-08-05 Gp41 epitope and uses thereof for the treatment of hiv infections Abandoned AU2003255866A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2002A001781 2002-08-06
IT001781A ITMI20021781A1 (en) 2002-08-06 2002-08-06 GP41 EPITOPE AND ITS USES IN THE TREATMENT OF HIV INFECTIONS.
PCT/IB2003/003149 WO2004014945A1 (en) 2002-08-06 2003-08-05 Gp41 epitope and uses thereof for the treatment of hiv infections

Publications (2)

Publication Number Publication Date
AU2003255866A8 true AU2003255866A8 (en) 2004-02-25
AU2003255866A1 AU2003255866A1 (en) 2004-02-25

Family

ID=31503941

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003255866A Abandoned AU2003255866A1 (en) 2002-08-06 2003-08-05 Gp41 epitope and uses thereof for the treatment of hiv infections

Country Status (3)

Country Link
AU (1) AU2003255866A1 (en)
IT (1) ITMI20021781A1 (en)
WO (1) WO2004014945A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013110790A1 (en) * 2012-01-26 2013-08-01 Institut National De La Sante Et De La Recherche Medicale (Inserm) Vaccine compositions for hiv prevention and treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8087994A (en) * 1993-10-26 1995-05-22 Syntello Inc. Inhibition of hiv mucosal infection

Also Published As

Publication number Publication date
ITMI20021781A1 (en) 2004-02-07
AU2003255866A1 (en) 2004-02-25
WO2004014945A1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
EP1390029A4 (en) Phenylindoles for the treatment of hiv
AP2081A (en) Oligomeric peptides and their use for the treatment of HIV infections
EP1696784A4 (en) Bioconjugated nanostructures, methods of fabrication thereof, and methods of use thereof
EP1392292A4 (en) Pyranoindazoles and their use for the treatment of glaucoma
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
AU5618501A (en) Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2001265253A1 (en) Treatment of hiv using hyperthermia
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
AU2002363973A8 (en) Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
AU2002368331A1 (en) Passive hyperimmune antibody therapy in the treatment of anthrax
AU2003291886A1 (en) Thiophenederivatives for the treatment of flavivirus infections
AU2002322082A1 (en) Pharmaceutical composition for the treatment of viral infection
AU2003301012A1 (en) Use of beta-defensins for treating hiv infections
GB0300078D0 (en) Composition for the treatment of HIV and AIDS
AU2003255866A8 (en) Gp41 epitope and uses thereof for the treatment of hiv infections
AU2003258983A8 (en) Combinations for the treatment of fungal infections
EP1687022A4 (en) Renta: an hiv immunogen and uses thereof
WO2002053587A3 (en) Polypeptide inducing hiv-neutralising antibodies
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU2003276159A1 (en) Immunisation against components of the human immunodeficiency virus (hiv)
EP1383563A4 (en) Methods for the treatment of hiv and other viruses
AU2002237845A1 (en) Thioxazinoquinolones useful for the treatment of viral infections
SI1366080T1 (en) Natural antibodies active against hiv virus
AU2002313005B2 (en) Use of glycoprotein for the treatment and re-epithelisation of wounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase